SpinQ and DIVBIO Enter Strategic Collaboration to Advance Quantum-Enabled Drug Discovery

2026.07.29 · Press Release Quantum computerSuperconducting quantum computer

SpinQ has entered into a strategic collaboration with DIVBIO Pharmaceutical Co., Ltd. to explore how quantum computing can support innovative drug discovery and development.

The collaboration will focus on several key stages of the R&D process, including molecular design, virtual screening, molecular simulation, and related computational workflows. By combining SpinQ’s quantum computing capabilities with DIVBIO’s expertise in biopharmaceutical research and commercialization, the two companies aim to evaluate practical application pathways for quantum technologies in real-world drug development.

 

 

As the complexity of modern drug discovery continues to grow, the industry is placing increasing demands on computational efficiency, modeling accuracy, and interdisciplinary collaboration. In this context, quantum computing is attracting growing interest for its potential in areas such as molecular simulation, target affinity analysis, protein structure prediction, and drug candidate screening.

Under the collaboration, SpinQ will provide quantum computing platforms, algorithm design and optimization, and technical support tailored to relevant research scenarios. DIVBIO will contribute application-driven research insight, domain expertise in biopharmaceutical R&D, and experimental validation to help assess how quantum methods can be integrated into practical discovery workflows.

 

 

Beyond joint application research, the two parties also plan to explore broader collaboration opportunities based on specific project needs, including joint R&D and industrialization initiatives, the development of a quantum computing-biopharma joint innovation platform, and continued technical exchange between teams.

 

 

The collaboration reflects a shared belief that as quantum technologies continue to advance, their role in life sciences and pharmaceutical innovation will become increasingly important. By working together, SpinQ and DIVBIO aim to expand the practical boundaries of quantum computing in drug discovery and contribute to the long-term development of this emerging interdisciplinary field.